Video Updates - Page 942

Listed by most recent

Chairman Chaffetz Q&A - U.S. Department of Education: Investigation of the CIO

Chairman Chaffetz Q&A - U.S. Department of Education: Investigation of the CIO

4/5/2016, 1:35 PM

Chairman Chaffetz Preface - Examining the Flint Water Crisis

Chairman Chaffetz Preface - Examining the Flint Water Crisis

4/5/2016, 1:35 PM

Rep. Chaffetz Opener - Examining Federal Administration of the Safe Drinking Water Act in Flint, MI

Rep. Chaffetz Opener - Examining Federal Administration of the Safe Drinking Water Act in Flint, MI

4/5/2016, 1:35 PM

Chairman Chaffetz Opener - Examining the Flint Water Crisis

Chairman Chaffetz Opener - Examining the Flint Water Crisis

4/5/2016, 1:35 PM

Rep. Gosar Q&A - Examining the Flint Water Crisis

Rep. Gosar Q&A - Examining the Flint Water Crisis

4/5/2016, 1:35 PM

Rep. Russell Q&A - Examining the Flint Water Crisis

Rep. Russell Q&A - Examining the Flint Water Crisis

4/5/2016, 1:35 PM

Rep. Mulvaney Q&A - Examining the Flint Water Crisis

Rep. Mulvaney Q&A - Examining the Flint Water Crisis

4/5/2016, 1:35 PM

Rep. Palmer Q&A - Examining the Flint Water Crisis

Rep. Palmer Q&A - Examining the Flint Water Crisis

4/5/2016, 1:31 PM

Rep. Amash - Examining the Flint Water Crisis

Rep. Amash - Examining the Flint Water Crisis

4/4/2016, 5:02 PM

Mr. Mica Q&A - Developments in the Prescription Drug Market: Oversight

Mr. Mica Q&A - Developments in the Prescription Drug Market: Oversight

4/4/2016, 5:02 PM

Mr. Carter Q&A - Developments in the Prescription Drug Market: Oversight

Mr. Carter Q&A - Developments in the Prescription Drug Market: Oversight

4/4/2016, 5:02 PM

Mr. DesJarlais Q&A - Developments in the Prescription Drug Market: Oversight

Mr. DesJarlais Q&A - Developments in the Prescription Drug Market: Oversight

4/4/2016, 5:02 PM

Mr. Carter Q&A 2 - Developments in the Prescription Drug Market: Oversight

Mr. Carter Q&A 2 - Developments in the Prescription Drug Market: Oversight

4/4/2016, 5:02 PM

Mr. Carter Q&A Part 3 - Developments in the Prescription Drug Market: Oversight

Mr. Carter Q&A Part 3 - Developments in the Prescription Drug Market: Oversight

4/4/2016, 5:01 PM

Hyperlapse Pharma Hearing

Hyperlapse Pharma Hearing

4/4/2016, 5:01 PM

Rep. Meadows Opener: The President's Waiver of Restrictions on the Visa Waiver Program

Rep. Meadows Opener: The President's Waiver of Restrictions on the Visa Waiver Program

4/4/2016, 2:16 PM

Mr. Hice Q&A - The President's Waiver of Restrictions on the Visa Waiver Program

Mr. Hice Q&A - The President's Waiver of Restrictions on the Visa Waiver Program

4/4/2016, 2:15 PM

Chairman Chaffetz on the need to review the IRS

Chairman Chaffetz on the need to review the IRS

4/4/2016, 2:15 PM

Chairman Chaffetz explains why we have zero confidence in the IRS's ability to retain records

Chairman Chaffetz explains why we have zero confidence in the IRS's ability to retain records

4/4/2016, 2:15 PM

Mr Jordan

Mr Jordan

4/4/2016, 2:15 PM